Quality of Life in Patients With Stem Cell Transplant After High Dose Chemotherapy: Validation Study of the Korean Version of the EORTC QLQ-HDC29
18 Years
80 Years
Both
Stem Cell Transplantation
Trial Information
Quality of Life in Patients With Stem Cell Transplant After High Dose Chemotherapy: Validation Study of the Korean Version of the EORTC QLQ-HDC29
Inclusion Criteria:
- Patients who are aged more than 18 years
- Patients who are diagnosed with hematologic malignancies and who are planned to
receive high-dose chemotherapy followed by allogeneic or autologous stem cell
transplantation (SCT)
- Patients who agree with the informed consent
Exclusion Criteria:
- Patients who are unable to complete the questionnaire due to the serious physical or
psychological morbidity
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Outcome Measure:
Reliability and validity of the Korean version of the EORTC HDC-29
Outcome Description:
Relaibility; Cronbach's alpha coefficient is used to evaluate the internal consistency. Validity; Persons's correlation coefficient is used to examine the correlation between similar dimensions of the different questionnaires.
Outcome Time Frame:
at the patient's hospitalization (before the SCT) and the outpatient clinic (three, six, and 12 months after their SCT)
Safety Issue:
No
Principal Investigator
Sung-Soo Yoon, MD, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Seoul National University Hospital
Authority:
Korea: Institutional Review Board
Study ID:
HDC29_Kor
NCT ID:
NCT01208532
Start Date:
September 2010
Completion Date:
December 2011
Related Keywords:
- Stem Cell Transplantation
Name | Location |
|---|
